Status:
UNKNOWN
Oxidative Stress Lowering Effect of Simvastatin and Atorvastatin.
Lead Sponsor:
Amsterdam UMC, location VUmc
Conditions:
Diabetes Mellitus
Hypertension
Eligibility:
All Genders
18-80 years
Phase:
PHASE4
Brief Summary
Background: HMG-CoA reductase inhibitors (statins) are effective lipid-lowering agents and are known to reduce cardiovascular events. Beneficial effects of statins seem to occur very early in the cour...
Detailed Description
Background HMG-CoA reductase inhibitors (statins) are effective lipid-lowering agents and are known to reduce cardiovascular events. It was initially assumed that cholesterol reduction by statins was ...
Eligibility Criteria
Inclusion
- Diabetes mellitus
- Hypertension
Exclusion
- chronic kidney disease K/DOQI stage 5
- use of statins
Key Trial Info
Start Date :
February 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2009
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT00404599
Start Date
February 1 2007
End Date
July 1 2009
Last Update
June 10 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
VU University Medical Center
Amsterdam, Netherlands, 1007 MB